Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws

Journal of Oral and Maxillofacial Surgery

Volumn 60, Issue 10, 2002, Pages 1103-1111

  Kaban, Leonard B ^a   Troulis, Maria J ^a   Ebb, David ^a   August, Meredith ^a   Hornicek, Francis J ^a   Dodson, Thomas B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ADOLESCENT; ADULT; ARTICLE; CANCER CONTROL; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CURETTAGE; ENUCLEATION; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; GIANT CELL TUMOR; HUMAN; JAW TUMOR; MALE; NEUTROPENIA; RADIOGRAPHY; RASH; TUMOR BIOPSY; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 0036788290     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1053/joms.2002.34975     Document Type: Article

References (51)

1. Chuong R, Kaban LB: Diagnosis and management of jaw tumors in children. J Oral Maxillofac Surg 43:23, 1985
2. Chuong R, Kaban LB, Kozakewich H: Central giant cell lesions of the jaws: A clinicopathologic study. J Oral Maxillofac Surg 44:708, 1986
3. Ficarra G, Kaban LB, Hansen LS: Central giant cell lesions of the maxilla and mandible: A clinicopathologic study. Oral Surg 64:44, 1987
4. Kaban LB: Aggressive jaw tumors in children. Oral Maxillofac Clin North Am 5:249, 1993
5. Kaban LB: The biomedical technology revolution: Challenges and opportunities for oral and maxillofacial surgery. Int J Oral Maxillofac Surg 31:1, 2002
6. Yasko AW: Interferon therapy for vascular tumors of bone. Curr Opin Orthop 12:514, 2001
7. Sulh MA, Greco MA, Jiang T, et al: Proliferation index and vascular density of giant cell tumors of bone. Cancer 77:2044, 1996
8. Rock MG, Pritchard DJ, Unni KK: Metastasis from histologically benign giant cell tumors of bone. J Bone Joint Surg Am 66:269, 1984
9. Oda Y, Miura H, Tsuneyoshi M, et al: Giant cell tumor of bone: Oncological and functional results of long-term follow-up. Jpn J Clin Oncol 28:323, 1998
10. Terry BC, Jacoway JR: Management of central giant cell lesions: An alternative to surgical therapy. Oral Maxillofac Clin North Am 6:579, 1994
11. Harris M: Central giant cell granulomas of the jaws regress with calcitonin therapy. Br J Oral Maxillofac Surg 31:89, 1993
12. Pogrel MAP, Regezi J, Harris ST, et al: Calcitonin treatment for central giant cell granulomas of the mandible: Report of two cases. J Oral Maxillofac Surg 57:848, 1999
13. Kaban LB, Mulliken JB, Ezekowitz A, et al: Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alpha-2a. Pediatrics 103:1145, 1999
14. Brouty-Boye D, Zetter B: Inhibition of cell motility by interferon. Science 208:516, 1980
15. Sidky YA, Borden EC: Inhibition of angiogenesis by interferons: Effects on tumor- and lymphocyte-induced vascular responses. Cancer Res 47:5155, 1987
16. Dvorak HF, Gresser I: Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice. J Natl Cancer Inst 81:497, 1989
17. White CW, Sondheimer HM, Crouch EC, et al: Treatment of pulmonary hemangiomatosis with recombinant interferon alpha-2a. N Engl J Med 320:1197, 1989
18. Folkman J: Successful treatment of an angiogenic disease. N Engl J Med 320:1211, 1989
19. Orchard PJ, Smith CM, Woods WG, et al: Treatment of haemangioendotheliomas with alpha interferon. Lancet 2:565, 1989
20. Ezekowitz RAB, Mulliken JB, Folkman J: Interferon alpha-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 326:1456, 1992 [erratum appears in N Engl J Med 330:300, 1994]
21. Orchard PJ, Smith CM III, Woods WG, et al: Treatment of haemangioendotheliomas with alpha interferon. Lancet 2:565, 1989
22. Loughnan MS, Elder J, Kemp A: Treatment of a massive orbital capillary hemangioma with interferon alpha-2b: Short-term results. Arch Ophthalmol 110:1366, 1992
23. Hatley RM, Sabio H, Howell CG, et al: Successful management of an infant with a giant hemangioma of the retroperitoneum and Kasabach-Merritt syndrome with alpha-interferon. J Pediatr Surg 28:1356, 1993
24. White CW, Wolf SJ, Korones DN, et al: Treatment of childhood angiomatous diseases with recombinant interferon alpha-2a. J Pediatr 118:59, 1991
25. Blei F, Orlow SJ, Geronemus RG. Interferon alpha-2a therapy for extensive perianal and lower extremity hemangioma. J Am Acad Dermatol 29:98, 1993
26. Ricketts RR, Hately RM, Corden BJ, et al: Interferon alpha-2a for the treatment of complex hemangiomas of infancy and childhood. Ann Surg 219:605, 1994
27. Ohlms LA, Jones DT, McGill TJI, et al: Interferon alpha-2a therapy for airway hemangiomas. Ann Otol Rhinol Laryngol 103:1, 1994
28. MacArthur CJ, Senders CW, Katz J: The use of interferon alpha-2a for life-threatening hemangiomas. Arch Head Neck Surg 121:690, 1995
29. Mulliken JB, Boon LM, Takahashi K, et al: Pharmacologic therapy for endangering hemangiomas. Curr Opin Dermatol 2:109, 1995
30. Deb G, Donfrancesco A, De Sio L, et al: Treatment of hemangiomas of infancy and babies with interferon alpha-2a: Preliminary results. Int J Pediatr Oncol 3:109, 1996
31. Boon LM, Burrows PE, Paltiel HJ, et al: Hepatic vascular anomalies in infancy: A twenty-seven year experience. J Pediatr 129:346, 1996
32. Chang E, Boyd A, Nelson CC, et al: Successful treatment of infantile hemangiomas with interferon alpha-2b. J Pediatr Hematol Oncol 19:237, 1997
33. Folkman J, Mulliken JB, Ezekowitz RAB: Antiangiogenic therapy of haemangiomas with interferon A, in Stuart-Harris R, Penny R (eds): The Clinical Applications of the Interferons. London, England, Chapman & Hall Medical, 1997, pp 255-265
34. Sarkar M, Mulliken JB, Kozakewich HPW, et al: Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 100:1377, 1997
35. Barlow CF, Priebe CJ, Mulliken JB, et al: Spastic diplegia as a complication of interferon alpha-2a treatment of hemangiomas of infancy. J Pediatr 132:527, 1998
36. Zheng MH, Xu J, Robbins P, et al: Gene expression of vascular endothelial growth factor in giant cell tumors of bone. Hum Pathol 31:804, 2000
37. Kaya M, Wada T, Akatsuka T, et al: Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res 6:572, 2000
38. Collins A: Experience with anti-angiogenic therapy of giant cell granuloma of the facial bones. Ann R Australas Coll Dent Surg 15:170, 2000
39. Folkman J: Clinical applications of research on angiogenesis. N Engl J Med 333:1757, 1995
40. Nguyen M, Watanabe H, Budson AE, et al: Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 86:356, 1994
41. Marler JJ, Rubin JB, Trede NS, et al: Successful antiangiogenic therapy of a giant cell angioblastoma with interferon alfa 2b: Report of 2 cases. Pediatrics 109:37, 2002
42. Eftekhari F, Wallace S, Chuang VP, et al: Intraarterial manage ment of giant-cell tumors of the spine in children. Pediatr Radiol 12:289, 1982
43. Linn PP, Guzel VB, Maura MG, et al: Long-term followup of giant cell tumor of the sacrum treated with selective arterial embolization, in Yasko AW (ed): Interferon Therapy for Vascular Tumors of Bone. Curr Opin Orthop 12:514, 2001
44. Kaiser U, Neumann K, Havemann K: Generalized giant-cell tumour of bone: Successful treatment of pulmonary metastases with interferon alpha: A case report. J Cancer Res Clin Oncol 119:301, 1993
45. Dickerman JD: Commentary: Interferon and giant cell tumors. Pediatrics 103:1282, 1999
46. Strander H, Boethius J, Erhardt K: Does successful interferon treatment of tumor patients require life-long treatment? J Interferon Res 7:619, 1987
47. Kazanjian VH: Spontaneous regeneration of bone following excision of section of the mandible. Am J Orthod 32:242, 1946
48. Shuker S: Spontaneous regeneration of the mandible in a child. J Maxillofac Surg 13:70, 1985
49. Nagase M, Ueda K, Susuki, Y, et al: Spontaneous regeneration of the condyle following hemimandibulectomy by disarticulation. J Oral Maxillofac Surg 43:218, 1985
50. Adekeye EO: Rapid bone regeneration subsequent to subtotal mandibulectomy: Report of an unusual case. Oral Surg Oral Med Oral Pathol 44:521, 1997
51. Abukawa H, Kaban LB, Vacanti J, et al: Effect of interferon on porcine mesenchymal stem cells in vitro. J Dent Res 2002